Study Evaluating Prevenar in High-Risk Children

Update Il y a 4 ans
Reference: NCT00234338

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to estimate the local and systemic tolerability of Prevenar in children ages 2 to 5 years old in usual care settings.


Inclusion criteria

  • Pneumococcal disease

Links